{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001540159","name":"Edesa Biotech, Inc.","summary":"Edesa Biotech is a biopharmaceutical company developing therapies for inflammatory and immune-related diseases. Its pipeline includes EB06 (anti-CXCL10 monoclonal antibody) for vitiligo, EB01 (daniluromer cream) for allergic contact dermatitis, and EB05 (paridiprubart) for Acute Respiratory Distress Syndrome (ARDS). In October 2025, paridiprubart met primary and secondary endpoints in a Phase 3 ARDS study. The company in-licenses assets from academic institutions and biopharmaceutical companies and pursues government grants and partnerships for development.","people":[],"products":[{"name":"EB06 (anti-CXCL10 monoclonal antibody)","type":"platform","description":"Fully human monoclonal antibody targeting CXCL10 for treatment of moderate-to-severe nonsegmental vitiligo; Phase 2 study approved by Health Canada."},{"name":"EB01 (1.0% daniluromer cream)","type":"platform","description":"Phase 3-ready topical therapy for moderate-to-severe chronic Allergic Contact Dermatitis; currently at partnering stage."},{"name":"EB05 (paridiprubart)","type":"platform","description":"Host-Directed Therapeutic monoclonal antibody for ARDS; met primary and secondary endpoints in a truncated Phase 3 study in October 2025."}],"partnerships":[{"partner_name":"Government of Canada","partnership_type":"development","description":"2023 grant and funding award providing reimbursement for EB05 development expenses including manufacturing scale-up.","start_date":null},{"partner_name":"BARDA (Biomedical Advanced Research and Development Authority)","partnership_type":"development","description":"U.S. government-funded platform study investigating paridiprubart and other HDTs in hospitalized ARDS patients.","start_date":null},{"partner_name":"Health Canada","partnership_type":"development","description":"Regulatory approval granted to conduct Phase 2 proof-of-concept study of EB06 in moderate-to-severe nonsegmental vitiligo.","start_date":null}],"affiliations":[],"origin":{"leaf":"a55b2312aa0b24d450237c4875510233ce13b07c8ebaed95160dec892b48a719","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"d898648d31a9ad751c6ed4f6c3fa286cad68ee5b9c3f90f2620ba470f484f128","parent":"47050959d85c1df57f3f83d9a2a3d105dd63f8f2e985643089b29be269a6e43d","source":"0001171843-25-007914","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":98,"hourly_limit":500,"remaining":402,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}